Overview of Intramol
| Property | Description |
|---|---|
| Active ingredient | Timolol |
| Form | Ophthalmic solution (Eye drops) |
| Pharmacological class | Beta-blocker |
| Common use | Reduction of intraocular pressure (IOP) |
| Origin | Synthetic compound |
What is Intramol and How is it Classified?
Intramol is a prescription-only medicine that utilizes the synthetic compound Timolol as its core active ingredient, classified medically as a beta-adrenergic receptor antagonist, more commonly known as a beta-blocker (β-blocker). This classification defines the medication's precise, chemically defined action. The active substance itself is specifically identified as Timolol maleate.
Composition, Forms, and General Purpose
The medication uses Timolol as a single active ingredient product, typically administered as a sterile, aqueous ophthalmic solution (eye drops) for ocular administration. Although the active ingredient is also manufactured in oral tablets for systemic, non-ocular purposes, the ophthalmic solution is the relevant dosage form here, dissolving Timolol in a water-based vehicle. The general therapeutic purpose of this agent is to function as an ocular hypotensive agent, a role utilized for stabilizing eye pressure and lowering the pressure inside the eye.
The Timolol Mechanism: Basic Action
Timolol is chemically designated as a non-selective beta-adrenergic blocker (β-1 and β-2 antagonist), signifying its ability to block certain receptor signals across multiple receptor types. Its basic mechanism involves reduced fluid production of the aqueous humor within the eye, leading to a controlled reduction of pressure. This specific action, which minimizes the production rate of internal eye fluid, is the fundamental process by which Intramol achieves its general purpose of managing and stabilizing internal eye pressure.
Regulatory References
